Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer

IsraelRecruitingPHASE1, PHASE2

Conditions

Metastatic Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shaare Zedek Medical Center, Jerusalem, Israel
Contact: Study coordinator (Alberto Gabizon, MD, PhD) · alberto.gabizon@gmail.com · 0508685036
Contact: Study coordinator (Yair Plesser) · yairp@szmc.org.il · 0505204342

Study leads

Alberto A Gabizon, MD, PhD
Principal Investigator
Shaare Zedek MC

View source on ClinicalTrials.gov Contact study team (email)